Intelligent Bio Solutions (NASDAQ:INBS), Inc., through its wholly owned subsidiary, is focused on the design, development and marketing of rapid, real-time detection and identification systems for foodborne and environmental pathogens. The company’s flagship product, the RAPID-B System, integrates patented biosensor and fluorescence technologies to detect viable microorganisms in a fraction of the time required by traditional culture-based testing methods. This approach enables food processors, beverage producers, environmental testing laboratories and homeland security agencies to identify contaminants such as Escherichia coli O157:H7, Salmonella spp. and Listeria monocytogenes in under one hour.
In addition to the RAPID-B instrument, Intelligent Bio Solutions offers a portfolio of assay kits and consumables tailored for specific pathogen targets and sample matrices. These test kits have undergone evaluations by regulatory bodies including the U.S. Food and Drug Administration and the U.S. Department of Agriculture, and are used in quality control, process verification and regulatory compliance workflows. By shortening time-to-result and reducing labor and material costs, the company’s rapid testing solutions help organizations respond more quickly to contamination events and improve overall product safety.
Founded in 1998 and headquartered in Houston, Texas, Intelligent Bio Solutions serves a global customer base through direct sales and a network of distribution partners. The company’s leadership team combines expertise in biosensor engineering, microbiology and regulatory affairs to drive ongoing product innovation and market development. Looking ahead, Intelligent Bio Solutions seeks to expand its detection capabilities, broaden its application scope and enter new markets such as clinical diagnostics and pharmaceutical contamination monitoring.
